Cigarette smoking is known to promote tumor metastasis, but do e-cigarettes also have an impact? This mini review synthesizes the current literature on the topic and discusses potential public health implications.
Obecabtagene autoleucel has demonstrated promising antitumor activity and safety in adults with relapsed or refractory B-cell acute lymphoblastic leukemia.
Evidence-based guidelines from the Congress of Neurological Surgeons on the role of chemotherapy in patients with newly diagnosed WHO grade II diffuse glioma. Explore the latest recommendations.
Among patients with metastatic colorectal cancer and DNA repair deficiency, first-line nivolumab plus ipilimumab significantly improves progression-free survival versus chemotherapy.
Three of the four cases resulted in fatal outcomes despite aggressive treatment, emphasizing the poor prognosis of fulminant myocarditis related to immune checkpoint inhibitor therapy.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.
Please note, this webinar is not intended for healthcare professionals based in the US and UK.
Three of the four cases resulted in fatal outcomes despite aggressive treatment, emphasizing the poor prognosis of fulminant myocarditis related to immune checkpoint inhibitor therapy.
A patient treated with carboplatin for stage I seminoma developed hematuria and acute kidney injury. It is crucial to recognize this rare but serious complication and start treatment promptly to prevent further kidney damage.
A girl with typical signs and symptoms of hypercortisolemia experienced adrenal insufficiency while on oral ketoconazole. Ectopic ACTH syndrome due to a thymic neuroendocrine tumor was diagnosed.
How do nutrition, supplements and antibiotics impact patient outcomes?
Recent research suggests that the gut microbiome could be an important modulator of response to CAR T-cell therapy in patients with hematologic cancers.
Prof. Marion Subklewe takes us through the latest evidence, highlighting the impact of antibiotics, nutrition, and dietary supplements, and discusses how to devise interventions to improve patient outcomes.
Viral infections in humans often cause excessive inflammation. In some viral infections, inflammation can be serious and even fatal, while in other infections it can promote viral clearance. Viruses can escape from the host immune system via …
Atherosclerosis (AS) formation is enhanced by different mechanisms including cytokine generation, vascular smooth muscle cell proliferation, and migration. One of the recent treatments towards endothelial dysfunction and AS is Vinpocetine (VPN).
Patients undergoing CTx have unique oral and dental needs as cancer and its treatment often have direct and indirect impact on oral health. Attentive dental care tailored to the needs of CPs reduces oral complications [ 1 – 3 ], improves quality of …
Limited geographic access to health facilities is a major factor contributing to reduced utilization of health services, resulting in poorer health outcomes [ 1 ]. This issue is particularly critical in the context of patients with cancer, as their …
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.
A series of patient cases underpin this interactive webinar that aims to provide practical guidance on a multidisciplinary approach to managing patients with cutaneous T-cell lymphoma.
An independent symposium at the 10th COMy World Congress focusing on BCMA-targeting strategies for the treatment of multiple myeloma. Gain insights into the latest clinical data and the implications for clinical practice.
The evolving landscape of metastatic urothelial carcinoma brings with it many challenges, such as optimally sequencing therapies and managing adverse events. Navigate your way through these with the Ultimate mUC challenge game and expert-to-expert interviews.
Supported by:
Merck Healthcare KGaA, Darmstadt, Germany and Astellas
Patients with diabetes mellitus have an estimated 27% elevated lifetime risk of developing colorectal cancer (CRC), and are disproportionately from priority health disparities populations (e.g., low-income, Non-Hispanic Black and Hispanic) [ 1 , 2 …
Lung cancer screening (LCS) of high-risk individuals annually using Low Dose CT (LDCT) can reduce lung cancer mortality [ 1 , 2 ]. A meta-analysis of eight trials found a 21–25% increase in lung cancer diagnosis and a 19% reduction in lung cancer …
Life expectancy at birth in the European Union (EU) was estimated at 81 years in 2018. As life expectancy increases, the burden of noncommunicable diseases (NCDs) grows. In 2017, the main causes of death in the EU included cardiovascular diseases …
Turning the tide on chronic disease is a major health system priority and integral to improving health outcomes, services, and costs. Seventy-three percent of Canadians 65 years of age and older have at least 1 of the 10 most common cancers and/or …
Obecabtagene autoleucel has demonstrated promising antitumor activity and safety in adults with relapsed or refractory B-cell acute lymphoblastic leukemia.
Evidence-based guidelines from the Congress of Neurological Surgeons on the role of chemotherapy in patients with newly diagnosed WHO grade II diffuse glioma. Explore the latest recommendations.
